AI Article Synopsis
- Amnion allograft has unique wound-healing capabilities that have not been extensively studied in dentistry, particularly for oral wounds.
- It was applied alongside a coronally advanced flap technique to treat gingival recession, resulting in complete coverage and improved aesthetics after six months.
- The inherent properties of amnion allograft suggest it could serve as an effective alternative to traditional methods for treating gingival recession.
Article Abstract
Introduction: Amnion allograft has been used in the field of medicine for its exceptional wound-modulating properties. However, in the field of dentistry, only a limited number of reports have explored its potential in healing of oral wounds.
Materials And Methods: Amnion allograft in conjunction with coronally advanced flap has been used in the management of gingival recession.
Results: A complete coverage along with excellent esthetics and an improvement in gingival biotype was observed at 6 months postoperatively.
Discussion: Because of its inherent wound-modulating properties, amnion allograft may be used to enhance periodontal wound healing and enable tissue regeneration such as that in the coverage of gingival recession.
Conclusion: Amnion allograft may provide an alternative to other conventional methods of treating gingival recession.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147801 | PMC |
| http://dx.doi.org/10.4103/0976-237X.137900 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of a sterilization process for amniotic membrane allograft tissue using supercritical carbon dioxide and NovaKill.
Cell Tissue Bank
December 2024
The Center for Innovations and Biodesign, San Antonio, TX, USA.
Amniotic membrane is arguably one of the most popular biological wound dressings on the market today. Various growth factors and cytokines inherent to amniotic membrane tissue have been recognized as key mediators in wound healing and tissue regeneration, giving the tissue its clinical utility. Sterilization methodologies using irradiation are recognized as the gold standard in the field and routinely used to prepare tissue allografts, including amniotic membrane for transplantation.
View Article and Find Full Text PDFNovel Use of an Aseptically Processed Amnion-Chorion Placental Allograft to Complement Wound Closure in High-Risk Sternotomy Patients: Clinical Safety and Outcomes.
Cureus
November 2024
Department of Research, MTF Biologics, Edison, USA.
Objectives Wound dehiscence is defined as the partial or complete separation of the layers of a surgical wound. Wound dehiscence and infections are of significant concern in the field of surgery as they can lead to a range of complications, including infection, delayed healing, increased healthcare costs, and patient discomfort. For patients at high risk of sternal wound dehiscence and infection, optimization of wound closure is critical.
View Article and Find Full Text PDFA Randomized Controlled Clinical Trial Comparing the Use of High Purity Type-I Collagen-Based Skin Substitute vs. Dehydrated Human Amnion/Chorion Membrane in the Treatment of Diabetic Foot Ulcers.
Cureus
December 2024
Plastic Reconstructive and Aesthetic Surgery, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, IND.
Article Synopsis
- - Diabetic foot ulcers (DFUs) are a significant and expensive issue for diabetes patients, leading to increased healthcare costs and morbidity.
- - A study compared two treatments for DFUs: a high-purity type-I collagen skin substitute (HPTC) and dehydrated human amnion/chorion membrane (dHACM) over four weeks, with 28 patients participating.
- - Results showed that HPTC led to better healing outcomes, with 85.71% of patients achieving at least 50% wound size reduction compared to 50% for dHACM, suggesting HPTC may be a more effective treatment for chronic DFUs.
Article Synopsis
- * A narrative review evaluated the effectiveness of these products for conditions such as Achilles tendinopathy and nerve repairs, with pre-clinical studies showing encouraging results.
- * The increasing availability of amniotic-derived biologics in orthopedic practice offers potential benefits, but more research is needed to understand long-term effects and any possible complications.
Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy.
Ann Hematol
November 2024
Department of Plastic, Hand, and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Article Synopsis
- Allogeneic hematopoietic stem cell transplantation (alloSCT) is a key treatment for blood disorders, but chronic graft-versus-host disease (cGvHD) can cause severe skin ulcers that traditional therapies often can't heal.
- * A study analyzed three patients with difficult-to-treat ulcers from cGvHD who were treated with human amniotic membrane (hAM) transplantation, which has healing properties.
- * Results showed that hAM led to complete healing in two patients, reduced pain and infections, and decreased the need for frequent dressing changes, presenting it as an effective option when standard treatments fail.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!